Pete Norman
About Pete Norman
Pete Norman is the Senior Vice President of Government, Policy & Community Relations at Alkermes in Washington, DC, with over two decades of experience in government relations and policy within the pharmaceutical industry.
Current Role at Alkermes
Pete Norman serves as the Senior Vice President, Government, Policy & Community Relations at Alkermes. He has held this position in Washington, DC, since October 2013. In this role, he is responsible for overseeing government relations, forging community partnerships, and shaping policy initiatives that align with Alkermes' strategic goals.
Previous Experience at Eisai Inc.
Before joining Alkermes, Pete Norman worked at Eisai Inc. as the Senior Director, Government Affairs & Policy, Department Head. He held this role from 2008 to 2013, based in Washington, DC. During his tenure, he was the Head of the Washington, D.C. office and managed the company's government relations and policy advocacy efforts.
Educational Background
Pete Norman holds a Juris Doctor (J.D.) from The University of Toledo College of Law, where he studied from 1999 to 2002. He also attended The Catholic University of America, Columbus School of Law as a visiting student from 2001 to 2002. Prior to his legal education, he earned a bachelor’s degree in History from Adrian College, where he studied from 1995 to 1999.
Career Journey in Government and Policy
Pete Norman has more than 20 years of experience in government relations and policy, particularly within the biopharmaceutical industry. His career includes senior roles at several major pharmaceutical companies, including Amylin Pharmaceuticals, Millennium Pharmaceuticals, and Novo Nordisk. He also worked at the Biotechnology Industry Organization (BIO) and served as an intern and staff member for the U.S. Congress early in his career.
Professional Experience in Washington, DC
Pete Norman has spent over two decades working in various capacities in Washington, DC. His roles have ranged from Manager of Federal Government Relations at BIO to Senior Manager positions at biopharmaceutical companies like Novo Nordisk and Millennium Pharmaceuticals. His considerable experience also includes serving as Associate Director at Amylin Pharmaceuticals and Senior Director at Eisai Inc.